Mantle cell lymphoma of the iris treated by ibrutinib

被引：0
|
作者：
De Gauzy, T. Sales [1 ]
Oberic, L. [2 ]
Fournie, P. [1 ]
Soler, V. [1 ]
机构：
[1] CHU Toulouse, Ophthalmol Dept, Hop Pierre Paul Riquet, Allee Jean Dausset, F-31300 Toulouse, France
[2] IUCT Oncopole, Hematolgy Dept, Toulouse, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2018年 / 41卷 / 10期
关键词：
DIAGNOSIS;
D O I：
10.1016/j.jfo.2018.07.003
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E501 / E502
页数：2
相关论文
共 50 条
  • [41] Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
    Zhao, Xiaohong
    Lwin, Tint
    Silva, Ariosto
    Shah, Bijal
    Tao, Jiangchuan
    Fang, Bin
    Zhang, Liang
    Fu, Kai
    Bi, Chengfeng
    Li, Jiannong
    Jiang, Huijuan
    Meads, Mark B.
    Jacobson, Timothy
    Silva, Maria
    Distler, Allison
    Darville, Lancia
    Zhang, Ling
    Han, Ying
    Rebatchouk, Dmitri
    Di Liberto, Maurizio
    Moscinski, Lynn C.
    Koomen, John M.
    Dalton, William S.
    Shain, Kenneth H.
    Wang, Michael
    Sotomayor, Eduardo
    Tao, Jianguo
    NATURE COMMUNICATIONS, 2017, 8
  • [42] Ibrutinib shows promising results in the treatment of resistant mantle cell lymphoma
    Wraight, Sophie
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 7 - 7
  • [43] Ibrutinib shows promising results in the treatment of resistant mantle cell lymphoma
    Wraight, Sophie
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (02) : 105 - 105
  • [44] Ibrutinib and Ixazomib in Relapsed/Refractory Mantle Cell Lymphoma: Precog 0404
    Cohen, Jonathon B.
    Jegede, Opeyemi
    Portell, Craig A.
    Hamadani, Mehdi
    Diefenbach, Catherine S.
    David, Kevin A.
    Fletcher, Christopher D.
    Landsburg, Daniel J.
    Mantha, Suparna
    Kahl, Brad S.
    BLOOD, 2022, 140 : 6487 - 6488
  • [45] Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma
    Wang, Michael L.
    Jurczak, Wojciech
    Jerkeman, Mats
    Trotman, Judith
    Zinzani, Pier L.
    Belada, David
    Boccomini, Carola
    Flinn, Ian W.
    Giri, Pratyush
    Goy, Andre
    Hamlin, Paul A.
    Hermine, Olivier
    Hernandez-Rivas, Jose-Angel
    Hong, Xiaonan
    Kim, Seok Jin
    Lewis, David
    Mishima, Yuko
    Ozcan, Muhit
    Perini, Guilherme F.
    Pocock, Christopher
    Song, Yuqin
    Spurgeon, Stephen E.
    Storring, John M.
    Walewski, Jan
    Zhu, Jun
    Qin, Rui
    Henninger, Todd
    Deshpande, Sanjay
    Howes, Angela
    Le Gouill, Steven
    Dreyling, Martin
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (26): : 2482 - 2494
  • [46] A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
    Lee, Yong-Pyo
    Jung, Ye Ji
    Cho, Junhun
    Ko, Young Hyeh
    Kim, Won Seog
    Kim, Seok Jin
    Yoon, Sang Eun
    BLOOD RESEARCH, 2023, 58 (04) : 208 - 220
  • [47] Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
    Wang, Michael L.
    Rule, Simon
    Martin, Peter
    Goy, Andre
    Auer, Rebecca
    Kahl, Brad S.
    Jurczak, Wojciech
    Advani, Ranjana H.
    Romaguera, Jorge E.
    Williams, Michael E.
    Barrientos, Jacqueline C.
    Chmielowska, Ewa
    Radford, John
    Stilgenbauer, Stephan
    Dreyling, Martin
    Jedrzejczak, Wieslaw Wiktor
    Johnson, Peter
    Spurgeon, Stephen E.
    Li, Lei
    Zhang, Liang
    Newberry, Kate
    Ou, Zhishuo
    Cheng, Nancy
    Fang, Bingliang
    McGreivy, Jesse
    Clow, Fong
    Buggy, Joseph J.
    Chang, Betty Y.
    Beaupre, Darrin M.
    Kunkel, Lori A.
    Blum, Kristie A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (06): : 507 - 516
  • [48] Sudden Flank Pain in a Patient Receiving Ibrutinib for Mantle Cell Lymphoma
    Law, Yu Xi Terence
    Lee, Lui Shiong
    JAMA ONCOLOGY, 2018, 4 (01) : 118 - 119
  • [49] Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
    Xiaohong Zhao
    Tint Lwin
    Ariosto Silva
    Bijal Shah
    Jiangchuan Tao
    Bin Fang
    Liang Zhang
    Kai Fu
    Chengfeng Bi
    Jiannong Li
    Huijuan Jiang
    Mark B. Meads
    Timothy Jacobson
    Maria Silva
    Allison Distler
    Lancia Darville
    Ling Zhang
    Ying Han
    Dmitri Rebatchouk
    Maurizio Di Liberto
    Lynn C. Moscinski
    John M. Koomen
    William S. Dalton
    Kenneth H. Shain
    Michael Wang
    Eduardo Sotomayor
    Jianguo Tao
    Nature Communications, 8
  • [50] Bruton Tyrosine Kinase Is Commonly Expressed in Mantle Cell Lymphoma and Its Attenuation by Ibrutinib Induces Apoptosis of Mantle Cell Lymphoma Cells
    Cinar, M.
    Hamedani, F. Saei
    Mo, Z.
    Cinar, B.
    Amin, H. M.
    Alkan, S.
    MODERN PATHOLOGY, 2013, 26 : 325A - 325A
12345